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Abstract
This Private Equity project studies the benefits for a private equity firm on acquiring Kompuestos, a producer of 
masterbatches and other plastic compounds, focused on adapting its business to meet the current environmental 
concerns. Such premise, aligned with the underlying opportunities inherent to an overall shift from society 
towards sustainable practices comprises an interesting investment opportunity yielding a 3.3x money multiple.
The importance of plastics is undeniable, and its industry is expected to grow 4.2% annually until 2027, reaching 
a market value of approximately $ 754bn by 2027.
Kompuestos is a well-established firm within the European plastic compounds market, generating € 46.2m in 
revenue and an EBITDA of € 3.3m in 2019. 
I would first like to thank the group’s supervisor, Professor Inês Lopo de Carvalho, whose knowledge and experience were vital for the development of the 
Work Project. I would also like to thank the entire team of Professors, specially to Professor Fábio Santos, who provided constant guidance to the students. 




Private Equity Challenge – Group Presentation 
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o Valued at 9.4x EV/EBITDA at entry and exit, Kompuestos
yields a total return of 3.3x MM over the 6-year investment 
period and a 21.8% IRR
A. Introduction | Executive summary
Kompuestos delivers high returns to institutional investors, yielding a 3.3x MM and a 21.8% IRR
Company overview Market overview
Entry rationale Exit and returns
o The plastic industry is characterized by a fragmented market
where large companies cohabit with smaller ones. The
combined global industry is expected to experience strong
growth over the investment period and is predicted to reach a
market volume of approximately $ 721bn by 2025
o Strongest growth is expected from the bioplastic solutions
market with an expected CAGR from 2019 to 2026 of 16%
o The strong growth is fuelled by several trends in the
underlying end markets such as the rise in demand of
recycled plastic, bioplastics and larger focus on R&D
Sources In €m EBITDA x Uses In €m EBITDA x
Debt 11.5 3.1x EV 34.9 9.4x
Equity 24.4 6.6x Fees 1.0 0.3x
Nova School of Business and Economics | Private Equity Challenge: Kompuestos | January 2021
o Well established company with healthy cash flows
after intensive historical Capital expenditure; room for
margin optimization; leverageable balance sheet
Robust fundamentals1
o +1,200 cross sector worldwide clients, where the 3
biggest clients account for only 20% of sales
Diversified client pool2
o Actionable mega trends, significant growth
projections, increasing demand for strategic products
and shift of the market towards sustainability
Optimistic industry trends3
o Leadership with a good




o Wide range of quality
products to fulfil all
areas of demand,
including sustainable
solutions to surf in high
growth segments
Diversified product range5
Returns 2021E 2022E 2023E 2024E 2025E 2026E
Management MM 2.2x 3.3x 4.5x 5.9x 8.1x 10.7x
Management IRR 124.8% 82.1% 65.5% 55.9% 53.1% 48.4%
Fund MM 1.3x 1.6x 1.9x 2.2x 2.7x 3.3x
Fund IRR 29.5% 25.1% 23.1% 21.9% 22.0% 21.8%
o Kompuestos is a Spanish industrial
company dedicated to the production and
marketing of masterbatches and polymers
to the plastic industry. Their revenue is
divided in plastic derivatives made from
traditional resources and includes a
production unit dedicated to the bioplastic
solutions
o The company is present in +44 countries
has clients from several industries.
Kompuestos is based in Catalonia, Spain
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KPIs (in €m) 2020 2021 2022 2023 2024 2025 2026
Total revenue 47.2 50.1 53.1 56.4 59.9 63.6 67.7
Growth 2.1% 6.0% 6.1% 6.2% 6.2% 6.3% 6.3%
Gross profit 14.3 15.2 16.1 17.2 18.3 19.5 20.8
Gross profit margin 30.2% 30.3% 30.3% 30.4% 30.4% 30.5% 30.5%
Normalized EBITDA 3.7 4.4 4.9 5.6 6.2 7.3 8.5
EBITDA margin 7.9% 8.8% 9.3% 9.8% 10.4% 11.4% 12.5%
EBIT 0.1 1.9 2.4 3.0 3.6 4.6 5.8
EBIT margin 0.2% 3.8% 4.5% 5.3% 6.0% 7.2% 8.4%
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Sources: Statista, GrandViewResearch, Fortune Business Insights
1. Market overview | Plastics market & masterbatches focus
The market is undergoing a transformational period with solid growth expectations
Plastics market overview & outlook
o Plastics are essential in our society, with +350mT produced
annually used to produce industrial and consumer products
o Plastics have key characteristics such as versatility, moldability
and flexibility, along with the cost advantage and easy
manufacturing nature
o Polymers (plastics) are mainly derived from petrochemicals (e.g.
natural gas, crude oil). Environmental awareness has driven
higher demand for sustainable plastic solutions as innovative
and cleaner alternatives are being developed, turning to
renewable sources (e.g. food waste, corn starch, biomass,
vegetable oil, etc…)
o Global market value of plastics reached $ 560bn in 2019 and is
estimated to grow at a 4.2% CAGR until 2027, supported by the
increase of the infrastructure & construction, food & beverages,
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End life - cycle
Supply chain
Segment overview: Masterbatches
o Masterbatches are plastic additives, fillers and resins that allow manufacturers to add
colour or other enhancing characteristics to their plastic products (e.g. UV light
resistance, flame retardation, anti-microbials)
o It is a cheaper and easier alternative to buying fully compounded materials or compounding














Sources: Statista, GrandViewResearch, Fortune Business Insights, Ellen MacArthur Foundation, Plastics Europe, McKinsey & Company, Association of plastics manufacturers, Markets&Markets
1. Market overview | Masterbatches deep-dive
Commitment to the environment created opportunities for manufacturers, opening new high growth markets
Segment overview: masterbatches
o The masterbatch market is expected to reach $ 16.4bn by
2026, growing at a 5.5% CAGR from 2019-2026, mainly driven
by increased activity in the building & construction sectors
o The masterbatch market is quite fragmented, with the
presence of numerous players with varying sizes
− The larger firms make up 60% of the market, with the
rest distributed among smaller players
o The industry is highly competitive due to the low barriers to
entry, as is it not a capital-intensive business and most of
segments do not require major technology investments. This
results in low bargaining power with both clients and suppliers
o This creates a lot of room for consolidation, with companies
wishing to expand their distribution network, vertically integrate
across the supply chain and diversify their product mix, in order


















Compostable & biodegradable plastics:
o Biodegradable plastics forecasted to increase at a 16.7% CAGR from 2018-2027
o The production capacity of the biodegradables is estimated to grow at an annual 




Global market value in $ 









Circular economy: Commitment to sustainability, low/zero waste initiatives and use
of recycled materials creates high growth opportunities
R&D: Perpetual race for the creation of new value-added products and improvement
of the production processes
Waste management: Improvement in the waste management systems makes it
possible to give a new life to the plastic waste through new sustainable products
Plastics from renewable resources:
o Bioplastics are expected to grow at an annual rate of 16.2% from 2018-2026,
reaching $ 20bn, and increasing its market share in the plastics industry to 40% by
2040
1175 1200 1200 1190 1179 1244 1328
885 912 994 1026 1026 1113
1288
2017 2018 2019e 2020e 2021e 2022e 2023e
Biodegradable
Non-biodegradable
Global capacity of bioplastic production (in mT tons)
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2. Company overview | Company profile & supply chain position 
Plastic compounds producer moving towards sustainable plastic production with € 46.2m in revenue
Company profile
o Based in Barcelona, Kompuestos is a producer of masterbatches (colour, black, white and additive) and other plastic
compounds (such as bio resins and recycled polymers), being one of the biggest European producers of mineral fillers (with c.
10% market share in Europe and 5% globally globally) Their products, which have a high natural component, are globally used
as raw materials in many industries to produce all types of plastics
– Employs +70 employees across 2 production plants, generating a revenue of € 46.2m and an EBITDA of € 3.3m in 2019
o Kompuestos is listed in the Spanish Alternative Market (MAB) since 2019; the public offering aimed to raise capital to finance
the expansion of the bio products’ production capacity, following the spike in demand
o The firm’s current strategy consists of focusing on the development of economies of scale in the production of mineral fillers
and the production of bioplastics, for which it already attained the necessary certifications
o The company has strong environmental commitment, focusing on adding value to plastics and on reducing their carbon
footprint through sustainable innovation, developing biodegradable products and advanced plastic recycling technologies
Key figures
2 production plants 
30 lines of production
Present in +44 countries 
+1,200 clients
Diversified product 

















Masterbatches, fillers and additives
o Masterbatches: concentrated mixture of polymers with pigments
and/or additives. Used to colouring plastics or imparting other
properties (e.g., antioxidant, UV stabilizers) to them
o Fillers: materials added to plastic polymers to reduce the cost of the
compound, improve its properties and lower its carbon footprint. Can
be combined with additives to obtain the desired product features
o Additives: improve the performance of plastics, protecting them
against degradation by heat, ultraviolet rays, oxidation or other agents,
or providing specific features depending on the use of the final product
5
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o Kompuestos produces and sells traditional plastic compounds, seeking also to develop
greener and more sustainable alternatives, such as bio-based and biodegradable plastics
and plastic recycling technologies
2. Company overview | Product mix, company strategy & growth drivers




o In 2019, 92% of the firms’
revenue came from the
traditional products, 5%
from the bio solutions
and 3% from the
recycling and marketing
of raw materials
o Kompuestos’ strategy is to bring together the businesses of traditional plastics and of the bio, compostable and recyclable
plastics. The firm aims to move “towards a sustainable future” and to become a leader in the circular economy of plastics
o Organic growth has been Kompuestos’ main source of growth over the years
o Capacity increase and optimization in production lines to meet demand allowed for a fast revenue growth (real
production capacity tripled since 2016)
o R&D is a key element of the firm’s business model, allowing for a yearly introduction of 100 new formulas. The development
and introduction of new products has been a vital growth driver in the last few years (as of 2019, 80% of the firm’s
revenues derived from products released in the last 5 years). Kompuestos was an early identifier of the need to adapt to the
growing environmental concerns, doing so by using its R&D strengths to develop bioplastics and plastic recycling techniques
o As of 2019, the bio line of production was roughly 5,000 mT and is expected to keep growing as, in the coming years,
bioplastics are expected to be a significant growth driver, as they capture new clients and introduce more ecological
solutions to the existing ones
Company strategy and growth drivers
Real capacity increase
40 000 40 000



















o Kompuestos derives its revenue from the sale of the different
products included in the previously mentioned product lines
The company offers to its clients a diversified product portfolio, allocated to 3 different lines:
1. Traditional products: mineral fillers, colour, black, white and additive masterbatches
2. Bio solutions: biodegradable, compostable and some water soluble bio-based resins
3. Recycling & marketing of raw materials: production and sale of recycled plastic polymers
6
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Income Statement (in €m) 2015 2016 2017 2018 2019
Traditional products 27.7 35.3 41.3 42.3
Quantity sold (mT) 33 722 36 545 50 381 56 752
Bio solutions 2.3
Quantity sold (mT) 1 181
Recycling and marketing of 
raw materials
0.9 1.3 0.1 1.6
Quantity sold (mT) 726 1 066 69 1 355
Total revenues 25.1 28.5 36.6 41.4 46.2
Growth 13.9% 28.1% 13.1% 11.7%
Cost of Sales (16.3) (19.1) (26.5) (29.4) (32.3)
% of sales 65.2% 66.8% 72.6% 71.2% 69.8%
Gross profit 8.7 9.5 10.0 11.9 14.0
Gross margin 34.8% 33.2% 27.4% 28.8% 30.2%
Self-constructed assets 0.1 0.5 1.4 1.2 1.6
% of sales 0.3% 1.6% 3.8% 3.0% 3.5%
Personnel expenses (2.6) (2.9) (3.5) (3.3) (3.7)
% of sales 10.4% 10.2% 9.5% 8.1% 8.0%
Other operating expenses (5.2) (5.3) (5.8) (6.1) (8.2)
% of sales 20.9% 18.5% 16.0% 14.7% 17.8%
Normalized EBITDA 1.0 1.8 2.1 3.7 3.7




0.0 0.1 0.0 (0.3) (0.5)
EBITDA 1.0 1.8 2.4 3.8 3.2
EBITDA margin 3.9% 6.4% 6.6% 9.1% 6.9%
D&A 0.0 0.0 0.0 0.0 0.0
Net income (0.5) 0.1 0.1 0.5 0.2


















Total Revenues Gross Margin
Comments
1 Kompuestos has been experiencing a constant growth in revenues, translating into a CAGR of
16.6% between 2015 and 2019
o Increase in production capacity with the creation of a new production line in 2017, enlarging its
real capacity from 40,000mT to 78,000mT. As a result, total quantity sold increased 34.1% in
2018, from 37,611mT 50,450mT
o Creation and implementation of three new bio lines of products in 2018 and consequent results
in 2019 sales-wise, contributing 47.6% to total revenue growth
2 Gross margin has increased c. 2.8% since 2017
o The bio segment implemented in 2019 presents costs that are almost 2.43x higher than the
traditional business (€ 1,270 per mT sold) ones but have a much larger margin compared to
the latter one (€ 723 vs € 222 per mT)
o Traditional business has experienced decreasing costs since 2017, standing at € 520 per
mT in 2019
Income Statement
3. Historical financials | Income statement
Kompuestos has experienced a constant growth in revenues sustained by an increase in its production capacity
Source: Company data
5 A 10.7% increase in 2019 was the result of
strengthening the company's commercial,
research and development and production
structure in order to sustain the growth
targeted for the coming years. The total
number of employees increased from 69 in
2018 to 79 in 2019
4 Incremental R&D activity since 2017 (for bio solutions development) aligned with the new











Change in Net Working Capital (0.3) 0.0 1.9
Net Working Capital 5.1 5.1 3.2
Investment in Op NWC as % of Sales (0.82)% (0.07)% 4.43%
Total Debt 14.9 16.2 12.9
Net debt 14.6 14.0 11.9
Growth% 17% (4)% (15)%
Net debt/EBITDA 6.11x 3.64x 3.60x
Balance Sheet (in €m) 2017 2018 2019
Intangible assets 1.9 2.7 3.6
Property. plant and equipment 17.2 18.1 21.1
Total non-current assets 19.6 21.1 25.2
Inventories 5.4 6.7 7.1
Trade and other receivables 5.5 5.8 4.3
Cash and cash equivalents 0.3 2.2 1.1
Total current assets 11.4 14.9 13.1
Total equity 10.1 12.2 16.9
Total non-current liabilities 6.4 7.8 9.0
Trade and other payables 5.7 7.4 8.2
Total current liabilities 14.5 15.9 12.4
Comments Balance Sheet & Free Cash Flow
3. Historical financials | Balance sheet & Free Cash Flow
Kompuestos exhibits a healthy financial profile
Sources: Company data, GVC Gaesco Beka estimation for Kompuestos
25% decrease in 2019 over the previous year driven by increasing
exports with better collection periods, an over-all improvement in
customer collection management and a selective usage of factoring
financing lines. Decreasing cash conversion cycle towards more







NWC decreased 36.7% following a decrease in accounts receivables and increase in accounts
payable in 2019. Apart from 2019, Kompuestos has generally kept the NWC at stable values
Large cash balance to enable growth through product development and expansion Capex
77%-86% of Capex values were related to expansion which
has been one of Kompuestos’ main growth drivers. Such
increase in the real production capacity of the company
(made to keep up with the current and future growing
demand for plastics) is expected to continue until 2020, and
then stop. Consequently, Capex is expected to decrease
going forward, driven by a null Expansion Capex
4
Core operations do not take into consideration the one-off effects of non-recurring items, finance
income or exchange rate gains/losses. Through this breakdown it is possible to verify the CF from
the company’s core operations. In 2019, the FCF was impacted by a large investment in the
expansion of the production capacity, IPO costs and costs related with the refinancing of debt
6
Growing intangible assets driven by heavy investments in R&D and consequent increasing number
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Free Cash Flow (in €m) 2017 2018 2019
Operating profit 0.4 1.4 1.8
Recurrent Capex 0.0 0.0 (0.9)
Expansion Capex (2.8) (3.1) (4.5)
Intangibles Capex (0.5) (0.9) (0.5)
Working capital needs (0.5) (0.1) 1.8
FCF Core Business (1.7) (0.6) (0.9)
FCF Non Core Business 0.3 0.0 (0.7)






o Growing company, with a sustained growth in revenues
– CAGR of 17% (2016-2019) – a rising gross profit
(13% CAGR) and stable gross margins (c. 30%, in line
with the peers’ average)
o Growing normalized EBITDA (28% CAGR – 2016-
2019) sustained by an overall expansion of the firm
o Net debt to EBITDA ratio has been decreasing driven
by incremental EBITDA and diminishing debt
o Negative CF generation in the last 3 years due to high




Operations in a growing and fragmented market Diversified client base and product range, 
with sustainable solutions offered
Growth strategy and drivers
Meet traditional business demand
o Take advantage of the early
identification of the market shift to
bio plastics, the current constraints
imposed by regulations and the
knowledge acquired through R&D to
deliver higher quantities of bio
solutions, with increased quality and
diversification
o Increasing production of recycled
polymers and bio solutions allows
for a slight decline in COGS as a
percentage of revenues
o EBITDA margin expansion to meet
its peers’ average, mainly through
the optimization of other operating
expenses
o Producing polymers from recycled
plastics creates a new source of
revenue for the firm, while contributing
to reduce the consumption of virgin
polymers in the industry and allowing
Kompuestos to increase the share of











Broad plastics Masterbatches Recycled
plastics
Bioplastics
Markets' CAGR 2018-2026 Potential European leader in fillers and
bio solutions, present in +44 countries
+1,200 long-term clients, with no
evidences of a specific sector dependency:
diversification of clients hedge against
sector specific risks
Diversified product portfolio, offering 
sustainable solutions
Ability to be a main player in bio
solutions due to a superior position to
attack the shifts in the market, high
innovation capability and industry
expertise
o The traditional business expects a
steady growth, with the firm
adapting its production to a future
growing demand
o Traditional products’ clients are
important to the bio solution range
commercialization
Increase bio solutions’ production Increase efficiency
o Highly qualified professionals with relevant industry 
expertise
Well-established company with attractive financials
Kompuestos is a well-established firm, operating in a growing market, with growing sustainability concerns 
Sources: Team analysis, company data




5. Business plan | Revenue model
Solid revenue streams with strong opportunities to grow, notably from the bio segment
Revenue breakdown
Traditional total quant. sold (mT) 33 722 36 545 50 381 56 752 55 200 58 181 61 323 64 634 68 125 71 803 75 681
Traditional sales (in €m) 27.7 35.3 41.3 42.3 43.2 45.6 48.1 50.8 53.6 56.6 59.7
Growth 27.6% 17.0% 2.5% 2.1% 5.5% 5.5% 5.5% 5.5% 5.5% 5.5%
Revenue per mT 0.8 1.0 0.8 0.7 0.8 0.8 0.8 0.8 0.8 0.8 0.8
Bio solutions total quant. sold 
(mT)
1 181 1 206 1 400 1 625 1 887 2 190 2 543 2 952
Bio solutions sales (in €m) 2.3 2.4 2.7 3.2 3.7 4.3 5.0 5.8
Growth 2.1% 16.1% 16.1% 16.1% 16.1% 16.1% 16.1%
Revenue per mT 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0
Recycled raw materials total 
quant. sold (mT)
726 1 066 69 1 355 1 383 1 501 1 629 1 767 1 917 2 080 2 257
Raw materials sales (in €m) 0.9 1.3 0.1 1.6 1.6 1.8 1.9 2.1 2.3 2.5 2.7
Growth 46.8% -93.5% 1851.3% 2.1% 8.5% 8.5% 8.5% 8.5% 8.5% 8.5%
Revenue per mT 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2
Key Value Drivers
Installed production facility and previously increased real production capacity 
allows a quicker expansion across all business units
Traditional 











Revenue Breakdown (in €m) 2016 2017 2018 2019 2020E 2021E 2022E 2023E 2024E 2025E 2026E
Traditional total quantity sold (mt) 34.4 37.6 50.5 59.3 57.8 61.1 64.6 68.3 72.2 76.4 80.9
Total sales 28.5 36.6 41.4 46.2 47.2 50.1 53.1 56.4 59.9 63.6 67.7
Growth 28.1% 13.1% 11.7% 2.1% 6.0% 6.1% 6.2% 6.2% 6.3% 6.3%
o Sales grew at a 16.6% CAGR from 2015-2019, with Covid-19
disrupting Kompuestos of achieving a double-digit growth in 2020.
2H 2020 sales were computed based on a 2.1x multiplication factor,
easily explained by the fewer restrictive rules and increased
economic activity, as the normal deals of the 1st part of the year were
relegated to the 2nd. Being closely correlated with the food retail
business, a sector registering a +10% growth in 2020, the 2% growth
projected is surely not underestimating the Covid-19 impact
o Traditional sales, the backbone of the company, grew at a 15.2% CAGR
from 2016-2019, and are expected to follow the same pace of the
masterbatches market (5.5%) from 2021 onwards
o Bio solutions are forecasted to follow the market growth of 16.1% from
2021 onwards as the Kompuestos is in a good position to attack the
growing demand, and seize the opportunity given their new bio
production line, increased capacity installed and R&D efforts
o Recycled raw materials experienced some oscillations; however, the
production facilities are ready to mass produce this product, meeting the
market demand and the 8.5% expected market growth
Sources: Team analysis, company data
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EBITDA margin deconstructed forecast
5. Business plan | Operating model
Space for margin optimization and growth
EBITDA breakdown
Income Statement (in €m) 2016 2017 2018 2019 2020E 2021E 2022E 2023E 2024E 2025E 2026E
Total revenue 28.5 36.6 41.4 46.2 47.2 50.1 53.2 56.6 60.2 64.0 68.2
Traditional products COGS 18.5 25.6 29.4 29.7 30.3 32.0 33.8 35.6 37.6 39.7 41.9
% of sales 66.8% 72.6% 71.2% 70.2% 70.2% 70.2% 70.2% 70.2% 70.2% 70.2% 70.2%
Bio solutions COGS 1.5 1.5 1.7 2.0 2.3 2.7 3.1 3.6
% of sales 62.8% 62.8% 62.8% 62.8% 62.8% 62.8% 62.8% 62.8%
Recycled raw materials 
COGS
0.6 0.9 0.1 1.1 1.1 1.2 1.3 1.4 1.6 1.7 1.8
% of sales 66.8% 72.7% 71.2% 68.8% 68.8% 68.8% 68.8% 68.8% 68.8% 68.8% 68.8%
Total cost of sales 19.1 26.5 29.4 32.3 32.9 34.9 37.1 39.4 41.9 44.5 47.4
% of sales 66.8% 72.6% 71.2% 69.8% 69.8% 69.7% 69.7% 69.6% 69.6% 69.5% 69.5%
Gross profit 9.5 10.0 11.9 14.0 14.3 15.2 16.1 17.2 18.3 19.5 20.8
Gross profit margin 33.2% 27.4% 28.8% 30.2% 30.2% 30.3% 30.3% 30.4% 30.4% 30.5% 30.5%
Other operating income 0.5 1.4 1.2 1.6 1.1 1.7 1.8 1.9 2.1 2.2 2.3
% of sales 1.6% 3.8% 3.0% 3.5% 2.4% 3.4% 3.4% 3.4% 3.4% 3.4% 3.4%
Personnel expenses 2.9 3.5 3.3 3.7 3.8 4.1 4.4 4.7 5.0 5.3 5.6
% of sales 10.2% 9.5% 8.1% 8.0% 8.0% 8.2% 8.2% 8.2% 8.2% 8.2% 8.2%
Other operating expenses 5.3 5.8 6.1 8.2 7.9 8.4 8.6 8.9 9.2 9.1 9.0
% of sales 18.5% 16.0% 14.7% 17.8% 16.7% 16.7% 16.2% 15.7% 15.2% 14.2% 13.2%
D&A 1.1 1.7 2.3 1.8 2.5 2.5 2.5 2.6 2.6 2.7 2.7
% of sales 4.0% 4.7% 5.6% 4.0% 5.2% 5.0% 4.8% 4.6% 4.4% 4.2% 4.0%
EBIT 0.7 0.7 1.8 1.9 0.1 1.9 2.4 3.0 3.6 4.6 5.8
EBIT margin 2.4% 2.0% 4.3% 4.1% 0.2% 3.8% 4.5% 5.3% 6.0% 7.2% 8.4%
Normalized EBITDA 1.8 2.1 3.7 3.7 3.7 4.4 4.9 5.6 6.2 7.3 8.5
EBITDA margin 6.2% 5.8% 9.1% 7.9% 7.9% 8.8% 9.3% 9.8% 10.4% 11.4% 12.5%
Normalization adjustments 0.1 0.3 0.4 0.1 (1.2) 0.0 0.0 0.0 0.0 0.0 0.0
EBITDA 1.8 2.4 3.8 3.2 2.6 4.4 4.9 5.6 6.2 7.3 8.5
EBITDA margin 6.4% 6.6% 9.1% 6.9% 5.4% 8.8% 9.3% 9.8% 10.4% 11.4% 12.5%
o The traditional business is the one with the highest COGS as %
sales, with no significant changes in this ratio since 2016
o Regarding bio solutions, the peer average COGS as % of sales was
considered, being at a lower % when compared to the traditional
o In general, the gross profit margin of the recycled raw materials is
higher than the traditional. In 2019, the COGS as % of sales in this
segment were calculated by difference, resulting in a COGS as % of
sales of 68.8%
o Operating income margin was calculated using an average of the
last 3 years (3.4%), except for 2020, where the company was
impacted by Covid-19, registering 2.4% for the 1H 2020. In order to
avoid underestimations of the pandemic this same value was used
for the FY 2020. This item includes self constructed assets and
nonfinancial and other capital gains, the first one (non-cash income),
decline due to the deceleration of R&D, and the second declined due
to the decrease in capital gains
o Personnel expenses were calculated based on the number of
employees and revenue per employee, depreciation was calculated
based on the real production capacity installed and amortization
based on the R&D expenses
Market growth trend and lower
production cost in alternative products
Margins moving towards peer’s average, 






Sources: Team analysis, company data
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5. Business plan | Free cash flow
Kompuestos is expected to continuously generate cash, while EBITDA is expected to grow at a 15% CAGR
Comments
Cumulative cash flows for the firm (€m)
• Very strong EBITDA growth at c. 15% CAGR enabled through 
margin optimization and growth of core operations
1
• D&A dependent on the real capacity installed and investments 
made in intangibles
2
• Recurrent and Intangibles Capex is based on % sales,
growing in line with overall growth of the company. Expansion
Capex is dependent on the real capacity installed, that is
projected to remain constant after the capacity increase made
in 2020. The majority of the historical Capex was attributed to
the Expansion Capex, that is projected to be no longer
required
3
• NWC remains negative during the investment period4
• The FCF from core business includes the operating activities
took by the company without the effect of one-off items. From
this it is possible to have an idea of the CF from the normal
activity of the company, with the effect of the core operating
income and the core invested capital
5
• Accounts with one-off items, such as grants and other non-
recurrent expenses, take into account the increase in non-
core invested capital (current and noncurrent investments
made by the company not related with the core operations of
the company)
6
Sources: Team analysis, company data
Free Cash Flow (in €m) 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Core Business FCF
Core Result (NOPLAT) 0.3 1.1 1.4 0.9 1.4 1.8 2.2 2.7 3.5 4.3
Depreciation & Amort. 1.7 2.3 1.8 2.5 2.5 2.5 2.6 2.6 2.7 2.7
Operational Cash flow 2.0 3.4 3.2 3.4 3.9 4.4 4.8 5.3 6.2 7.1
Recurrent Capex 0.0 0.0 (0.9) (0.9) (1.0) (1.0) (1.1) (1.2) (1.3) (1.3)
Expansion Capex (2.8) (3.1) (4.5) (4.4) 0.0 0.0 0.0 0.0 0.0 0.0
Intangibles Capex (0.5) (0.9) (0.5) (0.7) (0.8) (0.8) (0.9) (0.9) (1.0) (1.0)
Working Capital needs (0.5) (0.1) 1.8 (2.0) (0.4) (0.4) (0.4) (0.5) (0.5) (0.6)
FCF Core Business (1.7) (0.6) (0.9) (4.6) 1.8 2.1 2.4 2.8 3.4 4.1
(
FCF Non-Core Business 0.3 0.0 (0.7) (0.9) 0.0 0.0 0.0 0.0 0.0 0.0
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6. Exit and returns | Capital structure
Debt schedule consists of senior loans A and B priced at 2.75% and 2.85% respectively, with a leverage of 3.1x EBITDA
Comments
o Total funds are sourced from an equity contribution of 6.6x
EBITDA (€ 24.4m) and leverage of 3.1x EBITDA (€ 11.5m)
o Total debt is composed by Tranche A with € 9.3m of
amortizable senior debt, and Tranche B with € 2.2m of senior
debt to be fully repaid in 2027. The equity strip comprises a
subordinated loan of € 19.5m and ordinary equity of € 4.9m.
Management team’s sweet equity contribution of € 0.7m is
100% of their combined yearly salary
o Total uses of funds, amounting to € 36.0m, are to be paid
for the EV of € 34.9m and fees of € 1.1m
o The EV is based on an entry multiple of 9.4x EBITDA
Sources and uses of funds
Sources: Team analysis, company data & Santander DCM team advisory





• Type of debt: Senior debt, 
tranches A and B, both secured
• Additional instruments: 
Acquisition Capex facility
• Maximum leverage: 3.1x EBITDA
• Pricing: 2-3% of interest rate
• Maturity: 6-7 years








Sources of funds (in €m) x EBITDA % Interest Uses of funds (in €m) %
Senior debt Normalized EBITDA 2020 3.7
Term Loan A 9.3 2.5x 25.8% 2.75% Multiple 9.4x
Term Loan B 2.2 0.6x 6.2% 2.85%
Total debt 11.5 3.1x 32.0%
Enterprise value 34.9 97
Fixed Return Instrument 19.5 4.3x 44.9%
Ordinary Equity 4.9 1.3x 13.7% Financing fees
Institutional Ords 4.2 DD fee 0.2 0.5
Management Sweet Equity 0.7 Arrangement fee 0.2 0.5
Other fees and expenses 0.7 2
Total equity 24.4 6.6x 68.0% Total fees 1.1 3






Debt Ordinary Shares Term A
Term B Sub-Loan Ords
16
6. Exit and returns | Debt repayment, credit statistics, exit returns & value creation 
Exiting in 2026 delivers a 3.3x MM to institutional investors and a 10.7x MM to the management team 
Institutional and management returnsCash-flows for debt service and repayment (in €m) 
Returns (€ m) 2021E 2022E 2023E 2024E 2025E 2026E
Management Exit Proceeds 1.7 2.5 3.4 4.4 6.0 7.9
Management Equity 0.7 0.7 0.7 0.7 0.7 0.7
Management MM 2.2x 3.3x 4.5x 5.9x 8.1x 10.7x
Management IRR 124.8% 82.1% 65.5% 55.9% 53.1% 48.4%
Institutional Investor Exit 
Proceeds
30.7 37.1 44.3 52.3 64.1 77.6
Institutional Investor Equity 23.7 23.7 23.7 23.7 23.7 23.7
Institutional Investor MM 1.3x 1.6x 1.9x 2.2x 2.7x 3.3x
Institutional Investor IRR 29.5% 25.1% 23.1% 21.9% 22.0% 21.8%
Credit statistics
Exit waterfall 2026 (in €m)
2021E 2022E 2023E 2024E 2025E 2026E
Cash Cover 1.5x 1.8x 1.5x 1.5x 1.6x 2.0x
Net Debt / EBITDA 2.0x 1.4x 0.8x 0.3x (0.2)x (0.7)x
Interest Cover 13.4x 16.7x 21.2x 28.9x 47.7x 116.2x
Sources: Team analysis, company data
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7. Exit strategy | Valuable strategic sale
The most attractive strategy is to pursue a strategic sale as potential synergies translate in a higher exit multiple
Strategic sale IPO & other alternativesSecondary sale
o Sale to a direct competitor or a company along
the supply chain, with the aim of expanding its
product mix or geographical reach, or looking to
vertically integrate its operations
1. Direct competitor looking to expand to the
European market, improve logistics or obtain
access to a large and diversified client base
2. Plastics good manufacturer aiming to
increase control over processes or improve
efficiencies by acquiring a supplier
o Synergies created support a higher exit
multiple following the potential for value creation
incentivizing buyers to pay a higher premium
o Given the highly fragmented nature of the
market, in 5-7 years, a wave of mergers and
acquisitions is highly probable
o Sale to a private equity firm as the market is
expected to remain attractive with potential to
implement alternative value added strategies
o Financial sponsors are likely to continue to have
large amounts of capital to invest following
increased demand from investors
o This exit usually allows for an easier and faster
process, with more flexible agreements, but the
price may not be as favourable when
compared to the strategic sale given that
synergies are less likely
o An ideal buyer would include a PE firm operating
company involved in the plastics industry looking
to pursue “buy-and-build” strategies, or in similar
geographies allowing for potential synergies to be
created
o IPO: A public offering on the Madrid Stock
Exchange has the potential to expose the firm to
a larger pool of investors, yet it is subject to a
high regulatory framework and highly
dependent on market conditions (e.g. investor
sentiment). Additionally, the transactions costs
involved, time required and restrictions imposed
by standard lock-up agreements reduce this
option’s attractiveness, specially considering the
size of Kompuestos
• Direct Listing: Alternative to traditional IPO when
there is no need to raise capital, being, given the
lack of underwriters, a cheaper option.
Additionally, there are no lock-up agreements,
yet it is still very dependant on market
conditions and investors’ perceptions
• Sale to the management/ founding family:
Management or founding family may be interested
in taking control of the company, however, this is
highly unlikely given the size of the transaction
• Dual-track process: Filling the IPO prospectus
while searching for a strategic buyer allows to
gain perception of both capital markets’ sentiment
and strategic buyers’ interest. This may increase
returns, yet it is very costly
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Business plan | Value creation: traditional products
Global masterbatches market expecting a 5.4% CAGR, mainly from packaging, construction and automotive industries
o Global masterbatches market is expected to grow at a 5.4% CAGR
o In Europe, the market growth comes mainly from three segments:
packaging, construction and automotive, which together represent more
than two thirds of the market
Strategy reasoning
o Mineral concentrates fillers are an important revenue source for
Kompuestos, being a low cost and low footprint product. The firm can use
of its strong market position to expand its fillers sale further
Strategy execution
o Acquisition of high-quality inputs to produce fillers, due to its geographical
position
o Efficient production, through economies of scale in acquisition of raw
materials and production brought by the market shared detained in the
mineral concentrates
o Take advantage of the synergies in the production of mineral
concentrates and black and white masterbatches (shared production line)
o Usage of the installed capacity that is not being used to meet future
growing demand
o Apply R&D findings on the introduction of product modifications to confer
them higher quality and diversity
Expected outcome   o Production of a huge variety of products, with constant innovation
introduced. Innovation is a key factor since it allows the firm to differentiate
itself from its competitors and it is valuable to clients (in 2019, 80% of the
company's turnover comes from products formulated in the last 5 years)
o Meet future growing demand, selling improved products 




Opportunity to expand the mineral concentrates market share







Plastic Glass Cement Wood Steel Paper Alumimium
Consumption growth rate (2018-2050)
2018-2030 2030-2050
Source: Team analysis
Project Repelplas: Development of masterbatches with repellent
properties to protect crops of high economic value against common pests
and swimming pools against mosquitos
Eurostar awarded additives project
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o Strong R&D investment to design, implement and improve the bio solutions offered:
Kompuestos is not only focused on developing bioplastics but also on ensuring that they are
as close substitutes as possible to the traditional ones. R&D is crucial to ensure product
quality and business success given that certain characteristics of traditional plastics are
harder to incorporate in bio-based plastics, due to the difference in the raw materials used to
produce them
o Acquisition of a new machinery to efficiently produce bioproducts (28 000 mT capacity) using
the IPO proceeds
o Market positioning by obtaining certifications for its products from TÜV Austria. Currently, the
firm holds 10 certifications and is on the process of obtaining 23 more.
New market trend
Business plan | Value creation: bio solutions
Kompuestos will further develop and diversify its bioplastics products using R&D findings and know-how 
o Kompuestos will be able to sell its bio solutions to its current
customers, as they will need to adapt their production to this
new sustainability concern and will rely on the firm to help
them doing so
o The firm will also most likely gain new clients, attracted by the
environmentally friendly business model
o In what regards costs, the production cost of this solution is
slightly higher than the traditional one. However, the selling
price is higher as well, paying-off in relative terms, revelling




o Growing environmental concern and increasing regulations have been putting
pressure on the plastics industry. Companies aim to shift from traditional to bio-based
plastics
o In 2015, bioplastics made up 2% of the industry. This share is expected to increase
20x by 2040
Firm’s sustainability goals 
o Kompuestos has a strong environmental commitment and, for that reason, is betting





Business plan | Value creation: production and sale of recycled polymers 
New market trend
Cost saving, revenue generating and sustainability-oriented process  
o The global recycled plastic market size is expected to
witness significant growth backed by increasing demand
from the packaging industry, with a CAGR of 8.5%
between 2019 and 2026
o As the firm included the circular economy philosophy in its
business model, it would be advantageous to exploit the
possibility of producing masterbatches from recycled
plastics
o The cost of virgin polymers depends on the cost of crude
oil and can vary significantly across the year. Recycled
polymer prices are not affected by this fluctuation, as they
are not directly connected to such price
Firm’s sustainability goals 
Cost purposes
o Kompuestos developed several R&D projects in order to integrate the recycled polymers
manufacturing activity into its current business
o Kompuestos developed new technologies that facilitate the process of recycling and reuse
of plastics as the “reactive extrusion” (differs from conventional extrusion because, during
the reactive extrusion process, not only the components are mixed, but there is also a




o Production, at a lower cost, of materials that are more sustainable and environmentally
friendly, allowing both the firm and its clients to move towards sustainability in plastic
production
o Generation of a new source of income by selling recycling polymers
o Reduction of the consumption of virgin polymer in the industry
1
o Historically, recycled plastics are cheaper than virgin ones. However, the fall in oil
prices in 2019 made virgin plastic cheaper. While, financially, it might be better for
brands to use virgin plastic sometimes, doing so may cause long-term damage to























Evolution of price differential – Virgin PET minus Recycled PET Flake
Source: Team analysis, S&P Global Platts
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Business plan | Value creation: operating efficiency 
Opportunity to improve the EBITDA margin, mainly through the contention of the other operating expenses 
o Other operating expenses is the most relevant item in the cost structure and
is far from reaching optimal levels. This includes external services, taxes and
losses, impairment, and variation of provisions for commercial operations.
Within the External services, it is possible to proceed the optimization through
three items: transportation, professional services and advertisement,
suppliers and other services
o The company is in an expansion phase to follow the demand for plastics and,
due to this, it is losing efficiency in some key areas. The costs are to be
decreased, by increasing scale, arranging better deals with services providers
and increasing the firm’s bargaining power. In the past the company proved
that a better efficiency can be achieved
Expected outcome
o Increased EBITDA margin
o Higher margins on the bio solutions business when compared to the
traditional business
o Although Kompuestos’ average gross profit margin is in line with its
peers’ average, its average EBITDA margin is lower (7% versus 10%)
o Kompuestos has been spending more on total operating expenses than
the peers’ average (23% versus 18%) on recent years and has still not
been able to cut these expenses and come closer to its peers
o The firm is tackling this business line for the first time and thus, it must be
particularly cautious to ensure as much production efficiency as possible
o Even though profit margins for bio solutions are higher, it is necessary to
ensure that the bio solutions branch will evolve, at least, in line with the
industry results
Strategy reasoning Strategy execution1 2
3
Identification of opportunities for improvements 
Bio solutions branch requires special attention
0% 5% 10% 15% 20% 25%
Total operating expenses (% sales)
EBITDA margin

















Three of Kompuestos’ largest clients, Armando Álvarez Group (largest Spanish transformer
of plastic film), Dopla Group (producer of disposable tableware and biodegradable food
containers) and Papier Mettler (leader in paper and plastic packaging), saw a jump in
demand following the new sanitary concerns during the pandemic
Business plan | Covid-19 impact
Kompuestos: impact & action
Geographical and client diversification allowed Kompuestos to limit the Covid-19 impact on revenue
Main effects of the pandemic on the industry
Source: Team analysis
o Kompuestos has presented, in early March 2020, a protocol with preventive measures to
ensure production continuity and preserve the safety of its staff
o Both production plants are operating to ensure that the firm’s supply is not affected
o The firm is continuously taking actions to guarantee the continuation of its operations under
the current market uncertainty and the creation of value for its shareholders
o Following the Coronavirus outbreak, during 1H 2020, revenue decreased 8.2% compared to the
same period of 2019
o There was a drop in demand from manufacturers in non-core industries, such as
automotive and furniture, however, this decrease was partly offset by a spike in orders from
clients connected to healthcare & hygiene as well as packaging
o Kompuestos’ geographical diversification contributed to avoid a sharp decline in revenues
as observed across various companies following the lockdowns
o Additionally, client diversification and the lack of reliance on particular industries allowed
Kompuestos to limit the impact of the pandemic, given that some clients were positively and
others negatively affected
Halted government action
As lawmarkers had to shift all their focus to Covid-19,
several actions aimed at reducing plastic
consumption were paused
Temporary high reliance on single-use plastics
The pandemic increased demand for single-use
plastics from the food packaging and healthcare
industries
Recession fears
With several countries facing recession alarms,
plastic’s afordability and practicality outweighs
environmental concerns
Cheaper raw materials
Drop in global production and the Russia-Saudi
Arabia price war caused oil prices to collapse,
making plastic cheaper to produce
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Business plan | Identified risks
The value creation might be jeopardized by external effects, such as industry regulations and changes in preferences  
o Biodegradable plastics generally have higher manufacturing costs than
conventional plastics, since their production processes are still in the
refinement phase and economies of scale have not yet been achieved
o Furthermore, biodegradable plastics have not yet reached a level of technical
development similar to that of conventional plastics, especially in areas such
as heat and impact resistance and gas permeability. These factors could limit
the market share of biodegradable plastics, which could affect the sales of the
company’s bio solutions business
o New products developed are subject to approval before being commercialized
and this may take longer than expected and be more costly than planed
o Imposition of restrictions in the traditional plastic consumption/production may
compromise the growth of the traditional business and increase the need to
exploit bio solutions further, which might increase costs in the short run
Overall risks
Changes in consumer preferences
o Increased promotion of anti-plastic campaigns by activist and
environmentalists could constrain overall demand for plastic, regardless of
their origin, type of product or biodegradability levels, leading to demand-
side challenges from manufacturers. Single use plastic are to be
extinguished, however, Kompuestos do not have a great exposure to this
market and the company have no dependency from a specific industry
New sources of competition
o The development of a new material as energy efficient and practical as
plastic could result in an overall drop in demand
Loss of clients
o Most of Kompuestos’ clients are SMEs which tend to be more affected by 
macroeconomic events as these do not have the resources necessary to 
cope with sharp drops in demand and liquidity shortages. Losing clients if 
these go out of business would put the company’s growth strategy at risk
Operating efficiency
o Inability to control operating expenses, due to higher rents and/or
transportation costs, failing to move towards peers’ EBITDA margin
o Inability to compete with virgin polymers prices in case of sustained
decreases in oil prices
o Inability to obtain recycled polymers with the same features of virgin ones
Traditional business









Private Equity Challenge – Individual Presentation
Private Equity – Investment opportunities for PE firms on 
a post pandemic scenario
26
Private Equity | Investment opportunities for PE firms on a post pandemic scenario
Despite the economic recession originated by the pandemic, there are still investment opportunities for PE firms
o The long-term horizon underlying PE investments creates room for recovery, exponential growth and consequent returns for
investors. This feature aligned with firms’ valuations negatively affected by the pandemic presupposes opportunities to invest
in attractive businesses at a lower entry multiple, increasing exit margins
o Covid-19 has impacted companies in many areas, from their workforces to the underlying supply chain, from the relation with
customers to the revenue streams. Consequently, there was a boost demand-wise for the persevering and also flexible capital
offered by the private equity industry, and this may exceed the inherent supply. Such dynamic has characterized prior cycles,
with the returns from private equity commitments made after global crises outperforming those made during other periods 1
o Businesses that previously presented great prospects but were not for sale may be considering additional funding alternatives,
something PE funds can offer followed by a well-structured path towards recovery 2
o “All PE funds, including credit and growth capital, have amassed an estimated $1.4 trillion war chest, ready for immediate
deployment. Private credit funds (…) have grown into an $800 billion industry” 3. Such money is now available to support firms
in ways that were not possible in previous crises
Source: (1) Morgan Stanley Investment Management. 2020. “The case for Private Equity investing amid the crisis”
(2) Menghi, J. Abrol, B. Savoy, E. 2020. “How can private equity firms help reverse the economic damage”
(3) Segal, J. 2020. “Private Equity Firms Won’t Waste Another Crisis”
There is room for favorable
valuations under a pandemic
scenario and consequent
favorable returns, contrasting
with the descending trend
affecting the majority of
businesses around the world.
As a result, Private Equity
firms may stand as a
distinctive source of capital
tailored to assist businesses
recover from the Covid-19
pandemic
Main reasons
“In the past two decades, funds that started deploying cash following a
crisis performed 68% higher than funds whose vintage years fell during
late-cycle peak economic growth (such as 1998 to 2000 or 2005 to 2007).
This may be due, in part, to private equity funds getting more favorable
deal pricing during market downturns” 1
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